GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (FRA:MM3) » Definitions » YoY EBITDA Growth

Merit Medical Systems (FRA:MM3) YoY EBITDA Growth : 33.42% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Merit Medical Systems YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Merit Medical Systems's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 33.42%.

Merit Medical Systems's EBITDA per Share for the three months ended in Mar. 2024 was €1.09.


Merit Medical Systems YoY EBITDA Growth Historical Data

The historical data trend for Merit Medical Systems's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems YoY EBITDA Growth Chart

Merit Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.48 -19.54 55.66 24.01 21.32

Merit Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.99 14.61 32.98 9.31 33.42

Merit Medical Systems YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Merit Medical Systems's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(3.597-2.965)/ | 2.965 |
=21.32 %

Merit Medical Systems's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(1.086-0.814)/ | 0.814 |
=33.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems (FRA:MM3) Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. Majority of the revenue is earned from Cardiovascular segment. United States generates majority of the revenue.

Merit Medical Systems (FRA:MM3) Headlines

No Headlines